Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

A summary of current health news, including the disbanding of a U.S. Justice Department unit focusing on food and drug safety ...

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

The U.S. Food and Drug Administration (FDA) is still negotiating whether to grant full approval to Novavax's COVID-19 vaccine ...

Measles would likely be the first eradicated disease to return, because it is so highly contagious, but other diseases like ...

Health-care companies rose as earnings continued to come in strong. AbbVie shares rose after the drugmaker posted earnings ahead of Wall Street targets.

Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.

At some point within the first hour of waking up, expose yourself to natural light, preferably by taking a quick walk, Kaur ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...